deCODE Announces Departure of Hannes Smarason

21-Jun-2004

Reykjavik. deCODE genetics announced that Hannes Smarason, Executive Vice President and Senior Business Officer, will be leaving the company to devote himself to his responsibilities as Chairman of the Board of Icelandair. Mr. Smarason will continue to work with deCODE as a consultant.

"Hannes joined deCODE shortly after its formation and in his seven years with the company, he has made a very significant contribution to deCODE's growth from a leader in human genetics research to an integrated biopharmaceutical company. Hannes was instrumental in building the company's strong foundation and has been a valued friend and member of the executive management team. All of us at deCODE thank him for his efforts and wish him success in his new endeavors," said Kari Stefansson, CEO of deCODE. "deCODE is now at a very exciting stage in its development - that of advancing a growing number of compounds into clinical development and on towards the marketplace. As we take our lead programs forward, we expect to bring into the company key people with experience in the regulatory, licensing and marketing aspects of pharmaceuticals to execute on the company's business strategy."

"It has been a privilege to work with Kari and the many talented people at deCODE. My time at deCODE has been both exciting and rewarding, and I am very proud to have contributed to building one of the most dynamic companies in biotechnology. deCODE is a remarkable enterprise and I look forward to following its success. I wish to thank everyone at deCODE for sharing with me their enthusiasm for making better medicine," said Hannes Smarason.

https://www.bionity.com/en/news/38112/decode-announces-departure-of-hannes-smarason.html